Using sibling designs to understand neurodevelopmental disorders: From genes and environments to prevention programming

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Wade, Mark ^a   Prime, Heather ^a   Madigan, Sheri ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATTENTION DEFICIT DISORDER; AUTISM; COGNITION; HIGH RISK POPULATION; HUMAN; MORBIDITY; NEUROANATOMY; PATHOGENESIS; RECURRENCE RISK; REVIEW; SIBLING; TWINS; ENVIRONMENT; GENETICS; MEDICAL RESEARCH; NEURODEVELOPMENTAL DISORDERS; RISK FACTOR;

BIOMEDICAL RESEARCH; ENVIRONMENT; HUMANS; NEURODEVELOPMENTAL DISORDERS; RISK FACTORS; SIBLINGS;

EID: 84938125402     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/672784     Document Type: Review

References (216)

1. S. Goldstein and C. R. Reynolds, Handbook of Neurodevelopmental and Genetic Disorders in Children, 2/e, Guilford Press, 2010.
2. R. Taurines, C. Schwenck, E. Westerwald, M. Sachse, M. Siniatchkin, and C. Freitag, "ADHD and autism: Differential diagnosis or overlapping traits? A selective review," ADHD Attention Deficit and Hyperactivity Disorders, vol. 4, no. 3, pp. 115-139, 2012.
3. A. Thapar, K. Langley, P. Asherson, and M. Gill, "Geneenvironment interplay in attention-deficit hyperactivity disorder and the importance of a developmental perspective," The British Journal of Psychiatry, vol. 190, no. 1, pp. 1-3, 2007.
4. J. Hallmayer, S. Cleveland, A. Torres et al., "Genetic heritability and shared environmental factors among twin pairs with autism," Archives of General Psychiatry, vol. 68, no. 11, pp. 1095-1102, 2011.
5. P. J. Landrigan, L. Lambertini, and L. S. Birnbaum, "A research strategy to discover the environmental causes of autism and neurodevelopmental disabilities," Environmental Health Perspectives, vol. 120, no. 7, pp. a258-a260, 2012.
6. P. J. Landrigan, "What causes autism? Exploring the environmental contribution," Current Opinion in Pediatrics, vol. 22, no. 2, pp. 219-225, 2010.
7. J.Mill and A. Petronis, "Pre-and peri-natal environmental risks for attention-deficit hyperactivity disorder (ADHD): The potential role of epigenetic processes in mediating susceptibility," Journal of Child Psychology and Psychiatry, vol. 49, no. 10, pp. 1020-1030, 2008.
8. R. K. Lenroot and J. N. Giedd, "The changing impact of genes and environment on brain development during childhood and adolescence: Initial findings from a neuroimaging study of pediatric twins," Development and Psychopathology, vol. 20, no. 4, pp. 1161-1175, 2008.
9. M. L. Ganz, "The lifetime distribution of the incremental societal costs of autism," Archives of Pediatrics and Adolescent Medicine, vol. 161, no. 4, pp. 343-349, 2007.
10. T. A. Lavelle, M. C. Weinstein, J. P. Newhouse, K. Munir, K. A. Kuhlthau, and L. A. Prosser, "Economic burden of childhood autism spectrum disorders," Pediatrics, vol. 133, no. 3, pp. e520-e529, 2014.
11. T. T. Shimabukuro, S. D. Grosse, and C. Rice, "Medical expenditures for children with an autism spectrum disorder in a privately insured population," Journal of Autism and Developmental Disorders, vol. 38, no. 3, pp. 546-552, 2008.
12. J. A. Doshi, P. Hodgkins, J. Kahle et al., "Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States," Journal of the American Academy of Child & Adolescent Psychiatry, vol. 51, no. 10, pp. 990.e2-1002.e2, 2012.
13. K. Secnik, A. Swensen, andM. J. Lage, "Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder," PharmacoEconomics, vol. 23, no. 1, pp. 93-102, 2005.
14. A. R. Swensen, H. G. Birnbaum, K. Secnik, M. Marynchenko, P. Greenberg, and A. Claxton, "Attention-deficit/hyperactivity disorder: Increased costs for patients and their families," Journal of the American Academy of Child & Adolescent Psychiatry, vol. 42, no. 12, pp. 1415-1423, 2003.
15. P. Howlin, S. Goode, J. Hutton, andM. Rutter, "Adult outcome for children with autism," Journal of Child Psychology and Psychiatry and Allied Disciplines, vol. 45, no. 2, pp. 212-229, 2004.
16. R. A. Barkley, M. Fischer, C. S. Edelbrock, and L. Smallish, "The adolescent outcome of hyperactive children diagnosed by research criteria: I.An 8-year prospective follow-up study," Journal of the American Academy of Child & Adolescent Psychiatry, vol. 29, no. 4, pp. 546-557, 1990.
17. R. A. Lasser, D.W. Goodman, P. Asherson et al., "Lifespan persistence of ADHD: The life transition model and its application," Journal of Clinical Psychiatry, vol. 73, no. 2, pp. 192-201, 2012.
18. S. M. Myers and C. P. Johnson, "Management of children with autism spectrum disorders," Pediatrics, vol. 120, no. 5, pp. 1162-1182, 2007.
19. C. Rice, "Prevalence of autism spectrum disorders: Autism and developmental disabilities monitoring network, United States, 2006," Morbidity and Mortality Weekly Report-Surveillance Summaries, vol. 58, no. SS10, pp. 1-20, 2009.
20. J. Baio, "Prevalence of autism spectrum disorders-autism and developmental disabilities monitoring network, 14 sites, United States, 2008," Morbidity and Mortality Weekly Report. Surveillance Summaries, vol. 61, no. 3, pp. 1-19, 2012.
21. Y. S. Kim, B. L. Leventhal, Y. J. Koh et al., "Prevalence of autism spectrum disorders in a total population sample," American Journal of Psychiatry, vol. 168, no. 9, pp. 904-912, 2012.
22. S. Chakrabarti and E. Fombonne, "Pervasive developmental disorders in preschool children: Confirmation of high prevalence," American Journal of Psychiatry, vol. 162, no. 6, pp. 1133-1141, 2005.
23. E. Fombonne, "Epidemiological surveys of autism and other pervasive developmental disorders: An update," Journal of Autismand Developmental Disorders, vol. 33, no. 4, pp. 365-382, 2003.
24. E. Fombonne, "The prevalence of autism," Journal of the American Medical Association, vol. 289, no. 1, pp. 87-89, 2003.
25. L.Wing, J. Gould, and C. Gillberg, "Autism spectrum disorders in the DSM-V: Better or worse than the DSM-IV?" Research in Developmental Disabilities, vol. 32, no. 2, pp. 768-773, 2011.
26. J. N. Constantino and R. D. Todd, "Autistic traits in the general population: A twin study," Archives of General Psychiatry, vol. 60, no. 5, pp. 524-530, 2003.
27. R. E. Rosenberg, J. K. Law, G. Yenokyan, J. McGready, W. E. Kaufmann, and P. A. Law, "Characteristics and concordance of autism spectrum disorders among 277 twin pairs," Archives of Pediatrics and AdolescentMedicine, vol. 163, no. 10, pp. 907-914, 2009.
28. A. Bailey, A. Le Couteur, I. Gottesman et al., "Autism as a strongly genetic disorder: Evidence from a British twin study," Psychological Medicine, vol. 25, no. 1, pp. 63-77, 1995.
29. A. Ronald, F. Happé, P. Bolton et al., "Genetic heterogeneity between the three components of the autism spectrum: A twin study," Journal of the American Academy of Child & Adolescent Psychiatry, vol. 45, no. 6, pp. 691-699, 2006.
30. P. Bolton, H. Macdonald, A. Pickles et al., "A case-control family history study of autism," Journal of Child Psychology and Psychiatry, vol. 35, no. 5, pp. 877-900, 1994.
31. A. M. Persico and T. Bourgeron, "Searching for ways out of the autism maze: Genetic, epigenetic and environmental clues," Trends in Neurosciences, vol. 29, no. 7, pp. 349-358, 2006.
32. W. R. Kates, C. P. Burnette, S. Eliez et al., "Neuroanatomic variation in monozygotic twin pairs discordant for the narrow phenotype for autism," The American Journal of Psychiatry, vol. 161, no. 3, pp. 539-546, 2004.
33. S. R.Mitchell, A. L. Reiss, D. H. Tatusko et al., "Neuroanatomic alterations and social and communication deficits in monozygotic twins discordant for autism disorder," American Journal of Psychiatry, vol. 166, no. 8, pp. 917-925, 2009.
34. H. V. Bohm and M. G. Stewart, "Brief report: On the concordance percentages for autistic spectrum disorder of Twins," Journal of Autism and Developmental Disorders, vol. 39, no. 5, pp. 806-808, 2009.
35. D. H. Geschwind, "Genetics of autism spectrum disorders," Trends in Cognitive Sciences, vol. 15, no. 9, pp. 409-416, 2011.
36. S. Ozonoff, G. S. Young, A. Carter et al., "Recurrence risk for autism spectrum disorders: A Baby Siblings Research Consortium study," Pediatrics, vol. 128, no. 3, pp. e488-e495, 2011.
37. S. J. Rogers, "What are infant siblings teaching us about autism in infancy?" Autism Research, vol. 2, no. 3, pp. 125-137, 2009.
38. J. N. Constantino, Y. Zhang, T. Frazier, A. M. Abbacchi, and P. Law, "Sibling recurrence and the genetic epidemiology of autism," The American Journal of Psychiatry, vol. 167, no. 11, pp. 1349-1356, 2010.
39. J. N. Constantino, A. Todorov, C. Hilton et al., "Autism recurrence in half siblings: Strong support for geneticmechanisms of transmission in ASD," Molecular Psychiatry, vol. 18, no. 2, pp. 137-138, 2013.
40. N. Risch, T. J. Hoffmann, M. Anderson, L. A. Croen, J. K. Grether, and G. C. Windham, "Familial recurrence of autism spectrum disorder: Evaluating genetic and environmental contributions," American Journal of Psychiatry, vol. 171, no. 11, pp. 1206-1213, 2014.
41. T. L. Arndt, C. J. Stodgell, and P. M. Rodier, "The teratology of autism," International Journal of Developmental Neuroscience, vol. 23, no. 2-3, pp. 189-199, 2005.
42. K. Stromland, V. Nordin, M. Miller, B. Akerstrom, and C. Gillberg, "Autism in thalidomide embryopathy: A population study," Developmental Medicine & Child Neurology, vol. 36, no. 4, pp. 351-356, 1994.
43. Y. Yamashita, C. Fujimoto, E. Nakajima, T. Isagai, and T.Matsuishi, "Possible association between congenital cytomegalovirus infection and autistic disorder," Journal of Autism andDevelopmental Disorders, vol. 33, no. 4, pp. 455-459, 2003.
44. B. Eskenazi, A. R.Marks, A. Bradman et al., "Organophosphate pesticide exposure and neurodevelopment in young Mexican-American children," Environmental Health Perspectives, vol. 115, no. 5, pp. 792-798, 2007.
45. A.Miodovnik, S. M. Engel, C. Zhu et al., "Endocrine disruptors and childhood social impairment," NeuroToxicology, vol. 32, no. 2, pp. 261-267, 2011.
46. A. M. Persico and S. Merelli, "Environmental factors in the onset of autism spectrum disorder," Current Developmental Disorders Reports, vol. 1, no. 1, pp. 8-19, 2014.
47. D. Dufour-Rainfray, P. Vourc'h, S. Tourlet, D. Guilloteau, S. Chalon, and C. R. Andres, "Fetal exposure to teratogens: Evidence of genes involved in autism," Neuroscience&Biobehavioral Reviews, vol. 35, no. 5, pp. 1254-1265, 2011.
48. K.Mevel, P. Fransson, and S. Bölte, "Multimodal brain imaging in autism spectrum disorder and the promise of twin research," Autism, vol. 19, no. 5, pp. 527-541, 2015.
49. N. Yirmiya, I. Gamliel, M. Shaked, and M. Sigman, "Cognitive and verbal abilities of 24-to 36-month-old siblings of children with autism," Journal of Autism and Developmental Disorders, vol. 37, no. 2, pp. 218-229, 2007.
50. J. Piven, P. Palmer, D. Jacobi, D. Childress, and S. Arndt, "Broader autism phenotype: Evidence from a family history study of multiple-incidence autism families," The American Journal of Psychiatry, vol. 154, no. 2, pp. 185-190, 1997.
51. K. M. Dalton, B.M. Nacewicz, A. L. Alexander, and R. J. Davidson, "Gaze-fixation, brain activation, and amygdala volume in unaffected siblings of individuals with autism," Biological Psychiatry, vol. 61, no. 4, pp. 512-520, 2007.
52. I. Gamliel, N. Yirmiya, D. H. Jaffe, O. Manor, and M. Sigman, "Developmental trajectories in siblings of children with autism: Cognition and language from 4 months to 7 years," Journal of Autism and Developmental Disorders, vol. 39, no. 8, pp. 1131-1144, 2009.
53. I. Gamliel, N. Yirmiya, and M. Sigman, "The development of young siblings of children with autism from 4 to 54 months," Journal of Autism and Developmental Disorders, vol. 37, no. 1, pp. 171-183, 2007.
54. G. Dawson, S. J. Webb, E. Wijsman et al., "Neurocognitive and electrophysiological evidence of altered face processing in parents of children with autism: Implications for a model of abnormal development of social brain circuitry in autism," Development and Psychopathology, vol. 17, no. 3, pp. 679-697, 2005.
55. R. Landa and E. Garrett-Mayer, "Development in infants with autism spectrum disorders: A prospective study," Journal of Child Psychology and Psychiatry and Allied Disciplines, vol. 47, no. 6, pp. 629-638, 2006.
56. A. Nadig, S. Ozonoff, G. S. Young, A. Rozga, M. Sigman, and S. J. Rogers, "Failure to respond to name is an indicator of possible autism spectrumdisorder," Archives of Pediatrics and Adolescent Medicine, vol. 161, pp. 378-383, 2007.
57. W. L. Stone, C. R. McMahon, P. J. Yoder, and T. A. Walden, "Early social-communicative and cognitive development of younger siblings of children with autism spectrum disorders," Archives of Pediatrics & Adolescent Medicine, vol. 161, no. 4, pp. 384-390, 2007.
58. N. Yirmiya, I. Gamliel, T. Pilowsky, R. Feldman, S. Baron-Cohen, and M. Sigman, "The development of siblings of children with autism at 4 and 14 months: Social engagement, communication, and cognition," Journal ofChild Psychology and Psychiatry, vol. 47, no. 5, pp. 511-523, 2006.
59. T. D. Cassel, D. S. Messinger, L. V. Ibanez, J. D. Haltigan, S. I. Acosta, and A. C. Buchman, "Early social and emotional communication in the infant siblings of children with autism spectrum disorders: An examination of the broad phenotype," Journal of Autism and Developmental Disorders, vol. 37, no. 1, pp. 122-132, 2007.
60. L. Zwaigenbaum, S. Bryson, T. Rogers, W. Roberts, J. Brian, and P. Szatmari, "Behavioral manifestations of autism in the first year of life," International Journal of Developmental Neuroscience, vol. 23, no. 2-3, pp. 143-152, 2005.
61. S. E. Bryson, L. Zwaigenbaum, J. Brian et al., "A prospective case series of high-risk infants who developed autism," Journal of Autism and Developmental Disorders, vol. 37, no. 1, pp. 12-24, 2007.
62. S. Ozonoff, A.-M. Iosif, F. Baguio et al., "A prospective study of the emergence of early behavioral signs of autism," Journal of the American Academy of Child & Adolescent Psychiatry, vol. 49, no. 3, pp. 256.e1-2-266.e1-2, 2010.
63. G. V. Polanczyk, E. G.Willcutt, G. A. Salum, C. Kieling, and L. A. Rohde, "ADHD prevalence estimates across three decades: An updated systematic review and meta-regression analysis," International Journal of Epidemiology, vol. 43, no. 2, pp. 434-442, 2014.
64. E. G. Willcutt, A. E. Doyle, J. T. Nigg, S. V. Faraone, and B. F. Pennington, "Validity of the executive function theory of attention-deficit/hyperactivity disorder: A meta-analytic review," Biological Psychiatry, vol. 57, no. 11, pp. 1336-1346, 2005.
65. J. Biederman, "Attention-deficit/hyperactivity disorder: A selective overview," Biological Psychiatry, vol. 57,no. 11,pp. 1215-1220, 2005.
66. E. J.Mash andR. A. Barkley, Assessment of Childhood Disorders, Guilford Press, 2009.
67. S. Cortese, S. V. Faraone, E. Konofal, and M. Lecendreux, "Sleep in children with attention-deficit/hyperactivity disorder: Meta-analysis of subjective and objective studies," Journal of the American Academy of Child & Adolescent Psychiatry, vol. 48,no. 9, pp. 894-908, 2009.
68. S. V. Faraone, J. Biederman, and E. Mick, "The age-dependent decline of attention deficit hyperactivity disorder: A metaanalysis of follow-up studies," Psychological Medicine, vol. 36, no. 2, pp. 159-165, 2006.
69. V. Simon, P. Czobor, S. Bálint, Á. Mészáros, and I. Bitter, "Prevalence and correlates of adult attention-deficit hyperactivity disorder: Meta-analysis," British Journal of Psychiatry, vol. 194, no. 3, pp. 204-211, 2009.
70. S. Ozonoff, B. F. Pennington, and S. J. Rogers, "Executive function deficits in high-functioning autistic individuals: Relationship to theory of mind," Journal of Child Psychology and Psychiatry and Allied Disciplines, vol. 32, no. 7, pp. 1081-1105, 1991.
71. J.-O. Larsson, H. Larsson, and P. Lichtenstein, "Genetic and environmental contributions to stability and change of ADHD symptoms between 8 and 13 years of age: A longitudinal twin study," Journal of the American Academy of Child & Adolescent Psychiatry, vol. 43, no. 10, pp. 1267-1275, 2004.
72. F. Levy, D. A. Hay, M. McStephen, C. Wood, and I.Waldman, "Attention-deficit hyperactivity disorder: A category or a continuum? Genetic analysis of a large-scale twin study," Journal of the American Academy of Child & Adolescent Psychiatry, vol. 36, no. 6, pp. 737-744, 1997.
73. N. P. Friedman, A. Miyake, S. E. Young, J. C. DeFries, R. P. Corley, and J. K. Hewitt, "Individual differences in executive functions are almost entirely genetic in origin," Journal of Experimental Psychology: General, vol. 137, no. 2, pp. 201-225, 2008.
74. F. L. Coolidge, L. L. Thede, and S. E. Young, "Heritability and the comorbidity of attention deficit hyperactivity disorder with behavioral disorders and executive function deficits: A preliminary investigation," Developmental Neuropsychology, vol. 17, no. 3, pp. 273-287, 2000.
75. L. C. Bidwell, E. G. Willcutt, J. C. DeFries, and B. F. Pennington, "Testing for neuropsychological endophenotypes in siblings discordant for attention-deficit/hyperactivity disorder," Biological Psychiatry, vol. 62, no. 9, pp. 991-998, 2007.
76. S. V. Faraone, R. H. Perlis, A. E. Doyle et al., "Molecular genetics of attention-deficit/hyperactivity disorder," Biological Psychiatry, vol. 57, no. 11, pp. 1313-1323, 2005.
77. Z.Li, S.-H.Chang,L.-Y. Zhang, L. Gao, andJ.Wang, "Molecular genetic studies of ADHD and its candidate genes: A review," Psychiatry Research, vol. 219, no. 1, pp. 10-24, 2014.
78. E. Stergiakouli, J. Martin, M. Hamshere et al., "Shared genetic influences between attention-deficit/hyperactivity disorder (ADHD) traits in children and clinical ADHD," Journal of the American Academy of Child & Adolescent Psychiatry, vol. 54, no. 4, pp. 322-327, 2015.
79. J. Martin, M. L. Hamshere, E. Stergiakouli, M. C. O'Donovan, and A.Thapar, "Genetic risk for attention-deficit/hyperactivity disorder contributes to neurodevelopmental traits in the general population," Biological Psychiatry, vol. 76, no. 8, pp. 664-671, 2014.
80. A. P. Anokhin, A. C. Heath, and E.Myers, "Genetics, prefrontal cortex, and cognitive control: A twin study of event-related brain potentials in a response inhibition task," Neuroscience Letters, vol. 368, no. 3, pp. 314-318, 2004.
81. A. P. Anokhin, S. Golosheykin, and A. C. Heath, "Heritability of frontal brain function related to action monitoring," Psychophysiology, vol. 45, no. 4, pp. 524-534, 2008.
82. D. van't Ent, H. Lehn, E. M. Derks et al., "A structural MRI study inmonozygotic twins concordant or discordant for attention/hyperactivity problems: Evidence for genetic and environmental heterogeneity in the developing brain," NeuroImage, vol. 35, no. 3, pp. 1004-1020, 2007.
83. D. Van't Ent, C. E. M. Van Beijsterveldt, E. M. Derks et al., "Neuroimaging of response interference in twins concordant or discordant for inattention and hyperactivity symptoms," Neuroscience, vol. 164, no. 1, pp. 16-29, 2009.
84. C.Macare, T. Meindl, I. Nenadic, D. Rujescu, and U. Ettinger, "Preliminary findings on the heritability of the neural correlates of response inhibition," Biological Psychology, vol. 103, pp. 19-23, 2014.
85. W. Chen, K. Zhou, P. Sham et al., "DSM-IV combined type ADHD shows familial association with sibling trait scores: A sampling strategy for QTL linkage," The American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, vol. 147, no. 8, pp. 1450-1460, 2008.
86. N.Ma, R. Roberts,H.Winefield, andG. Furber, "The prevalence of psychopathology in siblings of children with mental health problems: A 20-year systematic review," Child Psychiatry & Human Development, vol. 46, no. 1, pp. 130-149, 2015.
87. G. Polanczyk,M. S. De Lima, B. L. Horta, J. Biederman, and L. A. Rohde, "The worldwide prevalence of ADHD: A systematic review and metaregression analysis," American Journal of Psychiatry, vol. 164, no. 6, pp. 942-948, 2007.
88. J. T. Nigg, L. G. Blaskey, J. A. Stawicki, and J. Sachek, "Evaluating the endophenotype model of ADHD neuropsychological deficit: Results for parents and siblings of children with ADHD combined and inattentive subtypes," Journal of Abnormal Psychology, vol. 113, no. 4, pp. 614-625, 2004.
89. S. V. Faraone, J. Biederman, D. Mennin, J. Gershon, and M. T. Tsuang, "A prospective four-year follow-up study of children at risk for ADHD: Psychiatric, neuropsychological, and psychosocial outcome," Journal of the American Academy of Child & Adolescent Psychiatry, vol. 35, no. 11, pp. 1449-1459, 1996.
90. J. Biederman, S. V. Faraone, K. Keenan, D. Knee, and M. T. Tsuang, "Family-genetic and psychosocial risk factors in DSMIII attention deficit disorder," Journal of the American Academy ofChild&Adolescent Psychiatry, vol. 29,no. 4, pp. 526-533, 1990.
91. S. V. Faraone, J. Biederman, B. K. Lehman et al., "Intellectual performance and school failure in children with attention deficit hyperactivity disorder and in their siblings," Journal of Abnormal Psychology, vol. 102, no. 4, pp. 616-623, 1993.
92. E. Sobanski, T. Banaschewski, P. Asherson et al., "Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): Clinical correlates and familial prevalence," Journal of Child Psychology and Psychiatry and Allied Disciplines, vol. 51, no. 8, pp. 915-923, 2010.
93. H. Christiansen,W. Chen, R. D. Oades et al., "Co-transmission of conduct problems with attention-deficit/hyperactivity disorder: Familial evidence for a distinct disorder," Journal of Neural Transmission, vol. 115, no. 2, pp. 163-175, 2008.
94. T. E. Froehlich, B. P. Lanphear, P. Auinger et al., "Association of tobacco and lead exposures with attention-deficit/hyperactivity disorder," Pediatrics, vol. 124, no. 6, pp. e1054-e1063, 2009.
95. S. K. Sagiv, S. W. Thurston, D. C. Bellinger, C. Amarasiriwardena, and S. A. Korrick, "Prenatal exposure to mercury and fish consumption during pregnancy and attentiondeficit/hyperactivity disorder-related behavior in children," Archives of Pediatrics & Adolescent Medicine, vol. 166, no. 12, pp. 1123-1131, 2012.
96. L. London, C. Beseler, M. F. Bouchard et al., "Neurobehavioral and neurodevelopmental effects of pesticide exposures," Neuro-Toxicology, vol. 33, no. 4, pp. 887-896, 2012.
97. G. Winneke, "Developmental aspects of environmental neurotoxicology: Lessons from lead and polychlorinated biphenyls," Journal of the Neurological Sciences, vol. 308, no. 1-2, pp. 9-15, 2011.
98. T. D. Banerjee, F.Middleton, and S. V. Faraone, "Environmental risk factors for attention-deficit hyperactivity disorder," Acta Paediatrica, vol. 96, no. 9, pp. 1269-1274, 2007.
99. L. J. Seidman, J. Biederman, M. C. Monuteaux, W. Weber, and S. V. Faraone, "Neuropsychological functioning in nonreferred siblings of children with attention deficit/hyperactivity disorder," Journal ofAbnormal Psychology, vol. 109, no.2,pp. 252-265, 2000.
100. N. N. J. Rommelse, M. E. Altink, J. Oosterlaan, C. J. M. Buschgens, J. Buitelaar, and J. A. Sergeant, "Support for an independent familial segregation of executive and intelligence endophenotypes in ADHD families," Psychological Medicine, vol. 38, no. 11, pp. 1595-1606, 2008.
101. R. J. Schachar, J. Crosbie, C. L. Barr et al., "Inhibition of motor responses in siblings concordant and discordant for attention deficit hyperactivity disorder," The American Journal of Psychiatry, vol. 162, no. 6, pp. 1076-1082, 2005.
102. S. S.-F. Gau and C.-Y. Shang, "Executive functions as endophenotypes in ADHD: Evidence from the Cambridge Neuropsychological Test Battery (CANTAB)," Journal of Child Psychology and Psychiatry, vol. 51, no. 7, pp. 838-849, 2010.
103. H. Uebel, B. Albrecht, P. Asherson et al., "Performance variability, impulsivity errors and the impact of incentives as genderindependent endophenotypes for ADHD," Journal of Child Psychology and Psychiatry, vol. 51, no. 2, pp. 210-218, 2010.
104. R. Marco, A. Miranda, W. Schlotz et al., "Delay and reward choice in ADHD: An experimental test of the role of delay aversion," Neuropsychology, vol. 23, no. 3, pp. 367-380, 2009.
105. B. Albrecht, D. Brandeis, H. Uebel et al., "Action monitoring in boys with attention-deficit/hyperactivity disorder, their nonaffected siblings, and normal control subjects: Evidence for an endophenotype," Biological Psychiatry, vol. 64, no. 7, pp. 615-625, 2008.
106. H. Van Ewijk, D. J. Heslenfeld, M. Luman et al., "Visuospatial working memory in ADHD patients, unaffected siblings, and healthy controls," Journal of Attention Disorders, vol. 18, no. 4, pp. 369-378, 2014.
107. A. J. A. M. Thissen, N. N. J. Rommelse, P. J. Hoekstra et al., "Attention deficit hyperactivity disorder (ADHD) and executive functioning in affected and unaffected adolescents and their parents: Challenging the endophenotype construct," Psychological Medicine, vol. 44, no. 4, pp. 881-892, 2014.
108. S. Durston, H. E. Hulshoff Pol,H. G. Schnack et al., "Magnetic resonance imaging of boys with attention-deficit/hyperactivity disorder and their unaffected siblings," Journal of the American Academy of Child and Adolescent Psychiatry, vol. 43, no. 3, pp. 332-340, 2004.
109. S. Durston, J. A. Fossella, M. J. Mulder et al., "Dopamine transporter genotype conveys familial risk of attention-deficit/hyperactivity disorder through striatal activation," Journal of the American Academy of Child and Adolescent Psychiatry, vol. 47, no. 1, pp. 61-67, 2008.
110. E. J. S. Sonuga-Barke,M.Thompson, J. Stevenson, andD.Viney, "Patterns of behaviour problems among pre-school children," Psychological Medicine, vol. 27, no. 4, pp. 909-918, 1997.
111. K. G. Smith and P. Corkum, "Systematic review of measures used to diagnose attention-deficit/hyperactivity disorder in research on preschool children," Topics in Early Childhood Special Education, vol. 27, no. 3, pp. 164-173, 2007.
112. E. J. Sonuga-Barke, J. Koerting, E. Smith, D. C. McCann, and M. Thompson, "Early detection and intervention for attentiondeficit/hyperactivity disorder," Expert Review ofNeurotherapeutics, vol. 11, no. 4, pp. 557-563, 2011.
113. G. Esser, S. Fischer, A. Wyschkon, M. Laucht, and M. H. Schmidt, "Predictors of hyperkinetic disorder-early recognition in childhood," Zeitschrift für Kinder-und Jugendpsychiatrie und Psychotherapie, vol. 35, no. 2, pp. 127-136, 2007.
114. J.M. Jester, J. T.Nigg,K.Adams et al., "Inattention/hyperactivity and aggression from early childhood to adolescence: Heterogeneity of trajectories and differential influence of family environment characteristics," Development and Psychopathology, vol. 17, no. 1, pp. 99-125, 2005.
115. D. Cicchetti and J. A. Blender, "A multiple-levels-of-analysis perspective on resilience: Implications for the developing brain, neural plasticity, and preventive interventions," Annals of the New York Academy of Sciences, vol. 1094, no. 1, pp. 248-258, 2006.
116. E. J. S. Sonuga-Barke and J. M. Halperin, "Developmental phenotypes and causal pathways in attention deficit/hyperactivity disorder: Potential targets for early intervention?" Journal of Child Psychology and Psychiatry, vol. 51,no. 4, pp. 368-389, 2010.
117. N. N. J. Rommelse, B. Franke, H. M. Geurts, C. A. Hartman, and J. K. Buitelaar, "Shared heritability of attentiondeficit/hyperactivity disorder and autism spectrum disorder," European Child & Adolescent Psychiatry, vol. 19, no. 3, pp. 281-295, 2010.
118. B. S. Pourcain, W. P. Mandy, J. Heron, J. Golding, G. D. Smith, and D. H. Skuse, "Links between co-occurring socialcommunication and hyperactive-inattentive trait trajectories," Journal of the American Academy of Child & Adolescent Psychiatry, vol. 50, no. 9, pp. 892.e5-902.e5, 2011.
119. M. Cooper, J.Martin, K. Langley, M. Hamshere, and A. Thapar, "Autistic traits in children with ADHD index clinical and cognitive problems," European Child & Adolescent Psychiatry, vol. 23, no. 1, pp. 23-34, 2014.
120. A. M. Reiersen, J. N. Constantino, H. E. Volk, and R. D. Todd, "Autistic traits in a population-basedADHDtwin sample," Journal of Child Psychology and Psychiatry andAlliedDisciplines, vol. 48, no. 5, pp. 464-472, 2007.
121. A. Ronald, E. Simonoff, J. Kuntsi, P. Asherson, and R. Plomin, "Evidence for overlapping genetic influences on autistic and ADHD behaviours in a community twin sample," Journal of Child Psychology and Psychiatry and Allied Disciplines, vol. 49, no. 5, pp. 535-542, 2008.
122. M. J. Taylor, T.Charman, E. B. Robinson et al., "Developmental associations between traits of autism spectrum disorder and attention deficit hyperactivity disorder: A genetically informative, longitudinal twin study," PsychologicalMedicine, vol. 43,no. 8, pp. 1735-1746, 2013.
123. M. Gill, R. Anney, and A. Mulligan, "Overlap between ADHD and autism-clinical and genetic evidence," Current Psychiatry Reviews, vol. 10, no. 2, pp. 143-155, 2014.
124. J. Martin,M.Cooper, M. L. Hamshere et al., "Biological overlap of attention-deficit/hyperactivity disorder and autism spectrum disorder: Evidence from copy number variants," Journal of the American Academy of Child & Adolescent Psychiatry, vol. 53, no. 7, pp. 761.e26-770.e26, 2014.
125. A. Mulligan, R. J. L. Anney, M. O'Regan et al., "Autism symptoms in attention-deficit/hyperactivity disorder: A familial trait which correlates with conduct, oppositional defiant, language and motor disorders," Journal of Autism and Developmental Disorders, vol. 39, no. 2, pp. 197-209, 2009.
126. N. N. J. Rommelse,M. E. Altink, E. A. Fliers et al., "Comorbid problems in ADHD: Degree of association, shared endophenotypes, and formation of distinct subtypes. Implications for a future DSM," Journal of Abnormal Child Psychology, vol. 37, no. 6, pp. 793-804, 2009.
127. E. Pettersson, H. Anckarsäter, C. Gillberg, and P. Lichtenstein, "Different neurodevelopmental symptoms have a common genetic etiology," Journal of Child Psychology and Psychiatry, vol. 54, no. 12, pp. 1356-1365, 2013.
128. H. Tager-Flusberg, "The origins of social impairments in autism spectrum disorder: Studies of infants at risk," Neural Networks, vol. 23, no. 8-9, pp. 1072-1076, 2010.
129. C. P. Johnson, S. M. Myers, P. H. Lipkin et al., "Identification and evaluation of children with autism spectrum disorders," Pediatrics, vol. 120, no. 5, pp. 1183-1215, 2007.
130. D. S. Mandell,W.W. Thompson, E. S.Weintraub, F. DeStefano, and M. B. Blank, "Trends in diagnosis rates for autism and ADHD at hospital discharge in the context of other psychiatric diagnoses," Psychiatric Services, vol. 56, no. 1, pp. 56-62, 2005.
131. M. Yeargin-Allsopp, C. Rice, T. Karapurkar, N. Doernberg, C. Boyle, and C. Murphy, "Prevalence of autism in a US metropolitan area," Journal of theAmericanMedical Association, vol. 289, no. 1, pp. 49-55, 2003.
132. L. Zwaigenbaum, S. Bryson, C. Lord et al., "Clinical assessment and management of toddlers with suspected autism spectrum disorder: Insights from studies of high-risk infants," Pediatrics, vol. 123, no. 5, pp. 1383-1391, 2009.
133. P. A. Filipek, P. J. Accardo, S. Ashwal et al., "Practice parameter: Screening and diagnosis of autism. Report of the quality standards subcommittee of the American Academy of Neurology and the Child Neurology Society," Neurology, vol. 55, no. 4, pp. 468-479, 2000.
134. S. L. Smalley, V. Kustanovich, S. L. Minassian et al., "Genetic linkage of attention-deficit/hyperactivity disorder on chromosome 16p13, in a region implicated in autism," The American Journal of Human Genetics, vol. 71, no. 4, pp. 959-963, 2002.
135. S. Dosreis, C. L. Weiner, L. Johnson, and C. J. Newschaffer, "Autism spectrum disorder screening and management practices among general pediatric providers," Journal of Developmental & Behavioral Pediatrics, vol. 27, no. 2, pp. S88-S94, 2006.
136. S.H. Landry, K. E. Smith, P. R. Swank,M. A. Assel, and S.Vellet, "Does early responsive parenting have a special importance for children's development or is consistency across early childhood necessary?" Developmental Psychology, vol. 37, no. 3, pp. 387-403, 2001.
137. M. W. Wan, J. Green, M. Elsabbagh, M. Johnson, T. Charman, and F. Plummer, "Quality of interaction between at-risk infants and caregiver at 12-15 months is associated with 3-year autism outcome," Journal of Child Psychology and Psychiatry, vol. 54, no. 7, pp. 763-771, 2013.
138. J. Green, M.W.Wan, J. Guiraud et al., "Intervention for infants at risk of developing autism: A case series," Journal of Autismand Developmental Disorders, vol. 43, no. 11, pp. 2502-2514, 2013.
139. A. M. Steiner, G.W. Gengoux, A. Klin, and K. Chawarska, "Pivotal response treatment for infants at-risk for autism spectrum disorders: A pilot study," Journal of Autism and Developmental Disorders, vol. 43, no. 1, pp. 91-102, 2013.
140. L. K. Koegel, A. K. Singh, R. L. Koegel, J. R. Hollingsworth, and J. Bradshaw, "Assessing and improving early social engagement in infants," Journal of Positive Behavior Interventions, vol. 16, no. 2, pp. 69-80, 2014.
141. J. Green, T. Charman, A. Pickles et al., "Parent-mediated intervention versus no intervention for infants at high risk of autism: A parallel, single-blind, randomised trial," The Lancet Psychiatry, vol. 2, no. 2, pp. 133-140, 2015.
142. F. Juffer, M. J. Bakermans-Kranenburg, and M. H. Van Ijzendoorn, Promoting Positive Parenting: An Attachment-Based Intervention, Routledge, 2012.
143. S. J. Webb, E. J. H. Jones, J. Kelly, and G. Dawson, "The motivation for very early intervention for infants at high risk for autism spectrumdisorders," International Journal of Speech-Language Pathology, vol. 16, no. 1, pp. 36-42, 2014.
144. N. Bauminger, "The facilitation of social-emotional understanding and social interaction in high-functioning children with autism: Intervention outcomes," Journal of Autism and Developmental Disorders, vol. 32, no. 4, pp. 283-298, 2002.
145. T. Klingberg, E. Fernell, P. J. Olesen et al., "Computerized training of working memory in children with ADHD-a randomized, controlled trial," Journal of the American Academy of Child & Adolescent Psychiatry, vol. 44, no. 2, pp. 177-186, 2005.
146. E. J. S. Sonuga-Barke, M. Thompson, H. Abikoff, R. Klein, and L. M. Brotman, "Nonpharmacological interventions for preschoolers with ADHD: The case for specialized parent training," Infants & Young Children, vol. 19, no. 2, pp. 142-153, 2006.
147. M. E. Toplak, L. Connors, J. Shuster, B. Knezevic, and S. Parks, "Review of cognitive, cognitive-behavioral, and neuralbased interventions for Attention-Deficit/Hyperactivity Disorder (ADHD)," Clinical Psychology Review, vol. 28,no. 5, pp. 801-823, 2008.
148. S. W. White, K. Keonig, and L. Scahill, "Social skills development in children with autism spectrum disorders: A review of the intervention research," Journal of AutismandDevelopmental Disorders, vol. 37, no. 10, pp. 1858-1868, 2007.
149. S. R. McConnell, "Interventions to facilitate social interaction for young children with autism: Review of available research and recommendations for educational intervention and future research," Journal of Autism and Developmental Disorders, vol. 32, no. 5, pp. 351-372, 2002.
150. B. L.Goodlin-Jones, F. Tassone, L.W. Gane, and R. J.Hagerman, "Autistic spectrum disorder and the fragile X premutation," Journal of Developmental & Behavioral Pediatrics, vol. 25, no. 6, pp. 392-398, 2004.
151. F. Farzin, H. Perry, D. Hessl et al., "Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation," Journal of Developmental & Behavioral Pediatrics, vol. 27, no. 2, pp. S137-S144, 2006.
152. J. E. Hunter, M. P. Epstein, S. W. Tinker, A. Abramowitz, and S. L. Sherman, "The FMR1 premutation and attentiondeficit hyperactivity disorder (ADHD): Evidence for a complex inheritance," Behavior Genetics, vol. 42, no. 3, pp. 415-422, 2012.
153. C. M. Kraan, D. R. Hocking, N. Georgiou-Karistianis et al., "Impaired response inhibition is associated with self-reported symptoms of depression, anxiety, and ADHD in female FMR1 premutation carriers," American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, vol. 165, no. 1, pp. 41-51, 2014.
154. F. J.Serajee,R.Nabi,H. Zhong, andA.H.MahbubulHuq, "Association of INPP1, PIK3CG, and TSC2 gene variants with autistic disorder: Implications for phosphatidylinositol signalling in autism," Journal of Medical Genetics, vol. 40, no. 11, article e119, 2003.
155. International Molecular Genetic Study of Autism Consortium (IMGSAC), "A genomewide screen for autism: Strong evidence for linkage to chromosomes 2q, 7q, and 16p," The American Journal of Human Genetics, vol. 69, no. 3, pp. 570-581, 2001.
156. P. Lucarelli, S. Palminiello, P. Saccucci et al., "Association study of autistic disorder and chromosome 16p," American Journal of Medical Genetics Part A, vol. 119, no. 2, pp. 242-246, 2003.
157. E. D'Agati, R. Moavero, C. Cerminara, and P. Curatolo, "Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex," Journal of ChildNeurology, vol. 24,no. 10,pp. 1282-1287, 2009.
158. M.N. Ogdie, S. E. Fisher, M. Yang et al., "Attention deficit hyperactivity disorder: Fine mapping supports linkage to 5p13, 6q12, 16p13, and 17p11,"The American Journal of Human Genetics, vol. 75, no. 4, pp. 661-668, 2004.
159. T. Marui, O. Hashimoto, E. Nanba et al., "Association between the neurofibromatosis-1 (NF1) locus and autism in the Japanese population," American Journal of Medical Genetics- Neuropsychiatric Genetics, vol. 131, no. 1, pp. 43-47, 2004.
160. O. Mbarek, S. Marouillat, J. Martineau, C. Barthélémy, J.-P. Müh, and C. Andres, "Association study of the NF1 gene and autistic disorder," American Journal ofMedical Genetics, vol. 88, no. 6, pp. 729-732, 1999.
161. K. Lidzba, S. Granström, J. Lindenau, and V.-F. Mautner, "The adverse influence of attention-deficit disorder with or without hyperactivity on cognition in neurofibromatosis type 1," Developmental Medicine & Child Neurology, vol. 54, no. 10, pp. 892-897, 2012.
162. C. M. Durand,C. Betancur, T. M. Boeckers et al., "Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders," Nature Genetics, vol. 39, no. 1, pp. 25-27, 2007.
163. R. Moessner, C. R.Marshall, J. S. Sutcliffe et al., "Contribution of SHANK3 mutations to autism spectrum disorder," The American Journal of Human Genetics, vol. 81, no. 6, pp. 1289-1297, 2007.
164. A. Denayer, H. Van Esch, T. De Ravel et al., "Neuropsychopathology in 7 patients with the 22q13 deletion syndrome: Presence of bipolar disorder and progressive loss of skills," Molecular Syndromology, vol. 3, no. 1, pp. 14-20, 2012.
165. G. Barnby, A.Abbott,N. Sykes et al., "Candidate-gene screening and association analysis at the autism-susceptibility locus on chromosome 16p: Evidence of association at GRIN2A and ABAT," The American Journal of Human Genetics, vol. 76, no. 6, pp. 950-966, 2005.
166. S. E. Fisher, C. Francks, J. T. McCracken et al., "A genomewide scan for loci involved in attention-deficit/hyperactivity disorder," The American Journal of Human Genetics, vol. 70, no. 5, pp. 1183-1196, 2002.
167. D. Q. Ma, P. L.Whitehead, M. M. Menold et al., "Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism," The American Journal of Human Genetics, vol. 77, no. 3, pp. 377-388, 2005.
168. A. L. Collins, D. Ma, P. L. Whitehead et al., "Investigation of autism and GABA receptor subunit genes in multiple ethnic groups," Neurogenetics, vol. 7, no. 3, pp. 167-174, 2006.
169. P. Purkayastha, A. Malapati, P. Yogeeswari, and D. Sriram, "A review on GABA/glutamate pathway for therapeutic intervention of ASD and ADHD," Current Medicinal Chemistry, vol. 22, no. 15, pp. 1850-1859, 2015.
170. S. Nagamitsu, Y. Yamashita, H. Tanigawa et al., "Upregulated GABA inhibitory function in AD/HD children with child behavior checklist-dysregulation profile: 123I-iomazenil SPECT study," Frontiers in Psychiatry, vol. 6, article 84, 2015.
171. J. S. Sutcliffe, R. J. Delahanty, H. C. Prasad et al., "Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors," The American Journal ofHuman Genetics, vol. 77,no. 2, pp. 265-279, 2005.
172. A. M. Coutinho, I. Sousa, M. Martins et al., "Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels," Human Genetics, vol. 121, no. 2, pp. 243-256, 2007.
173. L. Kent, U. Doerry, E. Hardy et al., "Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD): Analysis and pooled analysis,"Molecular Psychiatry, vol. 7, no. 8, pp. 908-912, 2002.
174. S. Curran, S. Purcell, I. Craig, P. Asherson, and P. Sham, "The serotonin transporter gene as a QTL for ADHB," American Journal of Medical Genetics B: Neuropsychiatric Genetics, vol. 134, no. 1, pp. 42-47, 2005.
175. K. D. Gadow, J. Roohi, C. J. DeVincent, and E. Hatchwell, "Association of ADHD, tics, and anxiety with dopamine transporter (DAT1) genotype in autism spectrum disorder," The Journal of Child Psychology and Psychiatry, vol. 49, no. 12, pp. 1331-1338, 2008.
176. E. Bowton, C. Saunders, I.A. Reddy et al., "SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking," Translational Psychiatry, vol. 4, no. 10, article e464, 2014.
177. E. H. Cook Jr., M. A. Stein,M.D. Krasowski et al., "Association of attention-deficit disorder and the dopamine transporter gene," The American Journal of Human Genetics, vol. 56, no. 4, pp. 993-998, 1995.
178. I. R.Gizer,C. Ficks, and I.D.Waldman, "Candidate gene studies of ADHD: A meta-analytic review," Human Genetics, vol. 126, no. 1, pp. 51-90, 2009.
179. S. Jacob, C. W. Brune, C. S. Carter, B. L. Leventhal, C. Lord, and E. H. Cook Jr., "Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism," Neuroscience Letters, vol. 417, no. 1, pp. 6-9, 2007.
180. S. Wu, M. Jia, Y. Ruan et al., "Positive association of the oxytocin receptor gene (OXTR) with autism in the ChineseHan population," Biological Psychiatry, vol. 58, no. 1, pp. 74-77, 2005.
181. J. Park, M.Willmott, G. Vetuz et al., "Evidence that genetic variation in the oxytocin receptor (OXTR) gene influences social cognition in ADHD," Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 34, no. 4, pp. 697-702, 2010.
182. N. Yirmiya, C. Rosenberg, S. Levi et al., "Association between the arginine vasopressin 1a receptor (AVPR1a) gene and autism in a family-based study: Mediation by socialization skills," Molecular Psychiatry, vol. 11, no. 5, pp. 488-494, 2006.
183. S. Y. Yang, S.-C. Cho, H. J. Yoo et al., "Association study between single nucleotide polymorphisms in promoter region of AVPR1A and Korean autism spectrum disorders," Neuroscience Letters, vol. 479, no. 3, pp. 197-200, 2010.
184. M. Wade, T. J. Hoffmann, and J. M. Jenkins, "Association between the arginine vasopressin receptor 1A (AVPR1A) gene and preschoolers' executive functioning," Brain and Cognition, vol. 90, pp. 116-123, 2014.
185. D. Braida, F. R. Guerini, L. Ponzoni et al., "Association between SNAP-25 gene polymorphisms and cognition in autism: Functional consequences and potential therapeutic strategies," Translational Psychiatry, vol. 5, no. 1, article e500, 2015.
186. F. R.Guerini, E. Bolognesi,M. Chiappedi et al., "SNAP-25 single nucleotide polymorphisms are associated with hyperactivity in autism spectrum disorders," Pharmacological Research, vol. 64, no. 3, pp. 283-288, 2011.
187. K. Brophy, Z. Hawi, A. Kirley, M. Fitzgerald, and M. Gill, "Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): Evidence of linkage and association in the Irish population,"Molecular Psychiatry, vol. 7, no. 8, pp. 913-917, 2002.
188. K. C. Kondapalli, A. Hack, M. Schushan, M. Landau, N. Ben-Tal, and R. Rao, "Functional evaluation of autism-associated mutations in NHE9," Nature Communications, vol. 4, article 2510, 2013.
189. M. Wagle and J. Holder, "Exonic deletion of SLC9A9 in autism with epilepsy (P4.338)," Neurology, vol. 82, no. 10, supplement, p. P4.338, 2014.
190. M. G. De Silva, K. Elliott, H.-H. Dahl et al., "Disruption of a novel member of a sodium/hydrogen exchanger family and DOCK3 is associated with an attention deficit hyperactivity disorder-like phenotype," Journal of Medical Genetics, vol. 40, no. 10, pp. 733-740, 2003.
191. J. Lasky-Su, B. M. Neale, B. Franke et al., "Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations," American Journal ofMedical Genetics Part B: Neuropsychiatric Genetics, vol. 147, no. 8, pp. 1345-1354, 2008.
192. E. Mick, A. Todorov, S. Smalley et al., "Family-based genomewide association scan of attention-deficit/hyperactivity disorder," Journal of the American Academy of Child & Adolescent Psychiatry, vol. 49, no. 9, pp. 898.e3-905.e3, 2010.
193. G. M. Orabona, K. Griesi-Oliveira, E. Vadasz et al., "HTR1B andHTR2C in autismspectrumdisorders inBrazilianfamilies," Brain Research, vol. 1250, pp. 14-19, 2009.
194. J. W. Smoller, J. Biederman, L. Arbeitman et al., "Association between the 5HT1B receptor gene (HTR1B) and the inattentive subtype of ADHD," Biological Psychiatry, vol. 59, no. 5, pp. 460-467, 2006.
195. Z. Hawi, M. Dring, A. Kirley et al., "Serotonergic system and attention deficit hyperactivity disorder (ADHD): A potential susceptibility locus at the 5-HT1B receptor gene in 273 nuclear families from a multi-centre sample," Molecular Psychiatry, vol. 7, no. 7, pp. 718-725, 2002.
196. S. Jamain, H. Quach, C. Betancur et al., "Mutations of the Xlinked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism," Nature Genetics, vol. 34, no. 1, pp. 27-29, 2003.
197. F. Laumonnier, F. Bonnet-Brilhault, M. Gomot et al., "X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family," The American Journal of Human Genetics, vol. 74, no. 3, pp. 552-557, 2004.
198. F. Lonardo, G. Parenti, D. V. Luquetti et al., "Contiguous gene syndrome due to an interstitial deletion in Xp22.3 in a boy with ichthyosis, chondrodysplasia punctata, mental retardation and ADHD," European Journal ofMedical Genetics, vol. 50,no. 4, pp. 301-308, 2007.
199. A. J. Stam, P. F. Schothorst, J. A. S. Vorstman, and W. G. Staal, "The genetic overlap of attention deficit hyperactivity disorder and autistic spectrum disorder," The Application of Clinical Genetics, vol. 2, pp. 7-13, 2009.
200. K. D. Gadow, C. J. Devincent, D. M. Olvet, V. Pisarevskaya, and E. Hatchwell, "Association of DRD4 polymorphism with severity of oppositional defiant disorder, separation anxiety disorder and repetitive behaviors in children with autism spectrum disorder," European Journal of Neuroscience, vol. 32, no. 6, pp. 1058-1065, 2010.
201. K. D. Gadow, C. J. DeVincent, V. Pisarevskaya et al., "Parentchild DRD4 genotype as a potential biomarker for oppositional, anxiety, and repetitive behaviors in children with autism spectrum disorder," Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 34, no. 7, pp. 1208-1214, 2010.
202. S. V. Faraone, A. E. Doyle, E. Mick, and J. Biederman, "Metaanalysis of the association between the 7-repeat allele of the dopamine D4 receptor gene and attention deficit hyperactivity disorder," The American Journal of Psychiatry, vol. 158, no. 7, pp. 1052-1057, 2001.
203. J. Feng, J. L. Sobell, L. L. Heston, E. H. Cook Jr., D. Goldman, and S. S. Sommer, "Scanning of the dopamine D1 and D5 receptor genes by REF in neuropsychiatric patients reveals a novel missense change at a highly conserved amino acid," American Journal ofMedical Genetics, vol. 81, no. 2, pp. 172-178, 1998.
204. J. Lasky-Su, J. Biederman, N. Laird et al., "Evidence for an association of the dopamine D5 receptor gene on age at onset of attention deficit hyperactivity disorder," Annals of Human Genetics, vol. 71, no. 5, pp. 648-659, 2007.
205. M. De Krom,W. G. Staal, R. A.Ophoff et al., "A common variant in DRD3 receptor is associated with autism spectrumdisorder," Biological Psychiatry, vol. 65, no. 7, pp. 625-630, 2009.
206. W. G. Staal, M. De Krom, and M. V. De Jonge, "Brief report: The dopamine-3-receptor gene (DRD3) is associated with specific repetitive behavior in autism spectrumdisorder (ASD)," Journal of Autism and Developmental Disorders, vol. 42, no. 5, pp. 885-888, 2012.
207. W. Retz, M. Rösler, T. Supprian, P. Retz-Junginger, and J. Thome, "Dopamine D3 receptor gene polymorphism and violent behavior: Relation to impulsiveness and ADHD-related psychopathology," Journal of Neural Transmission, vol. 110, no. 5, pp. 561-572, 2003.
208. L. K. Davis, H. C. Hazlett, A. L. Librant et al., "Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase a gene," American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, vol. 147, no. 7, pp. 1145-1151, 2008.
209. I. L. Cohen, X. Liu, C. Schutz et al., "Associationof autismseverity with a monoamine oxidase A functional polymorphism," Clinical Genetics, vol. 64, no. 3, pp. 190-197, 2003.
210. D. Verma, B. Chakraborti, A. Karmakar et al., "Sexual dimorphic effect in the genetic association of monoamine oxidase A (MAOA) markers with autism spectrum disorder," Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 50, pp. 11-20, 2014.
211. K.Domschke, K. Sheehan, N. Lowe et al., "Association analysis of the monoamine oxidase A and B genes with attention deficit hyperactivity disorder (ADHD) in an Irish sample: Preferential transmission of the MAO-A 941G allele to affected children," American Journal of Medical Genetics: Neuropsychiatric Genetics, vol. 134, no. 1, pp. 110-114, 2005.
212. I. Manor, S. Tyano, E. Mel et al., "Family-based and association studies of monoamine oxidase A and attention deficit hyperactivity disorder (ADHD): Preferential transmission of the long promoter-region repeat and its association with impaired performance on a continuous performance test (TOVA)," Molecular Psychiatry, vol. 7, no. 6, pp. 626-632, 2002.
213. H. J. Yoo, H. Cho, M. Park, S. Y. Yang, and S. A. Kim, "Association of the catechol-o-methyltransferase gene polymorphisms with korean autism spectrum disorders," Journal of Korean Medical Science, vol. 28, no. 9, pp. 1403-1406, 2013.
214. T. Guo, W. Wang, B. Liu, H. Chen, and C. Yang, "Catechol-Omethyltransferase Val158Met polymorphism and risk of autism spectrum disorders," Journal of International Medical Research, vol. 41, no. 3, pp. 725-734, 2013.
215. J. Eisenberg, G. Mei-Tal, A. Steinberg et al., "Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): Association of the high-enzyme activity val allele with ADHD impulsivehyperactive phenotype," American Journal of Medical Genetics, vol. 88, no. 5, pp. 497-502, 1999.
216. J. Biederman, J.W. Kim, A. E. Doyle et al., "Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: A preliminary study," American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, vol. 147, no. 8, pp. 1511-1518, 2008.